Kalehua Capital Management LLC
An institutional investment manager in DALLAS, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 2106181.
- Reported value$139.5m
- Positions49
Holdings: 49 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 23 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| EA Series Trust | ALPHA ARCH 1-3 | 02072L565 | 26.5 | 8.4% | 226,188 | Added+107,766 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 17.9 | 5.7% | 145,695 | Added+42,816 | |
| Veradermics IncMANE | COOMON STOCK | 922967104 | 17.9 | 5.7% | 145,695 | Added+42,816 | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 17.4 | 5.5% | 3,722,840 | Unchanged | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 17.4 | 5.5% | 3,722,840 | Unchanged | |
| Compass Pathways PlcCMPS | SPONSORED ADS | 20451W101 | 11.6 | 3.7% | 819,692 | Unchanged | |
| Compass Pathways PlcCMPS | SPONSORED ADS | 20451W101 | 11.6 | 3.7% | 819,692 | Unchanged | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 10.0 | 3.2% | 385,178 | Unchanged | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 10.0 | 3.2% | 385,178 | Unchanged | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 9.7 | 3.1% | 1,832,365 | Unchanged | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 9.7 | 3.1% | 1,832,365 | Unchanged | |
| Sionna Therapeutics IncSION | COM | 829401108 | 8.7 | 2.8% | 197,072 | Unchanged | |
| Sionna Therapeutics IncSION | COM | 829401108 | 8.7 | 2.8% | 197,072 | Unchanged | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 7.8 | 2.5% | 3,821,890 | Added+1,149,282 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 7.8 | 2.5% | 3,821,890 | Added+1,149,282 | |
| Pharvaris NV | COM | N69605108 | 6.9 | 2.2% | 198,772 | Unchanged | |
| Pharvaris NV | COM | N69605108 | 6.9 | 2.2% | 198,772 | Unchanged | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 6.7 | 2.1% | 685,644 | New+685,644 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 6.7 | 2.1% | 685,644 | New+685,644 | |
| Septerna IncSEPN | COM | 81734D104 | 6.5 | 2.1% | 194,544 | Unchanged | |
| Septerna IncSEPN | COM | 81734D104 | 6.5 | 2.1% | 194,544 | Unchanged | |
| Inflarx Nv | COM | N44821101 | 6.5 | 2.1% | 2,897,769 | New+2,897,769 | |
| Inflarx Nv | COM | N44821101 | 6.5 | 2.1% | 2,897,769 | New+2,897,769 | |
| Cyclerion Therapeutics Inc | COM | 23255M204 | 5.6 | 1.8% | 1,651,350 | New+1,651,350 | |
| Cyclerion Therapeutics Inc | COM | 23255M204 | 5.6 | 1.8% | 1,651,350 | New+1,651,350 | |
| Korro Bio IncKRRO | COM | 500946108 | 5.3 | 1.7% | 405,040 | Added+295,664 | |
| Uniqure Nv | SHS | N90064101 | 3.7 | 1.2% | 79,407 | Reduced−211,702 | |
| Uniqure Nv | SHS | N90064101 | 3.7 | 1.2% | 79,407 | Reduced−211,702 | |
| LeonaBio IncLONA | COM | 04746L203 | 3.6 | 1.2% | 393,701 | Unchanged | |
| LeonaBio IncLONA | COM | 04746L203 | 3.6 | 1.2% | 393,701 | Unchanged | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 3.6 | 1.2% | 139,000 | Unchanged | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 3.6 | 1.2% | 139,000 | Unchanged | |
| MoonLake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 3.4 | 1.1% | 175,734 | Unchanged | |
| MoonLake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 3.4 | 1.1% | 175,734 | Unchanged | |
| Adlai NortyeANL | SPONSORED ADS | 00704R109 | 2.6 | 0.8% | 226,415 | New+226,415 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 2.4 | 0.8% | 74,465 | Unchanged | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 2.4 | 0.8% | 74,465 | Unchanged | |
| Nuvectis Pharma IncNVCT | COM | 67080T108 | 1.8 | 0.6% | 100,000 | New+100,000 | |
| Nuvectis Pharma IncNVCT | COM | 67080T108 | 1.8 | 0.6% | 100,000 | New+100,000 | |
| Gossamer Bio Inc | COM | 38341P102 | 1.8 | 0.6% | 11,149,363 | Added+913,070 | |
| Gossamer Bio Inc | COM | 38341P102 | 1.8 | 0.6% | 11,149,363 | Added+913,070 | |
| Milestone Pharmaceuticals IncMIST | COM | 59935V107 | 1.7 | 0.5% | 1,269,237 | New+1,269,237 | |
| Milestone Pharmaceuticals IncMIST | COM | 59935V107 | 1.7 | 0.5% | 1,269,237 | New+1,269,237 | |
| Atyr Pharma IncATYR | COM NEW | 002120202 | 1.1 | 0.3% | 1,788,167 | New+1,788,167 | |
| Atyr Pharma IncATYR | COM NEW | 002120202 | 1.1 | 0.3% | 1,788,167 | New+1,788,167 | |
| Instil Bio IncTIL | COM NEW | 45783C200 | 0.8 | 0.2% | 99,600 | Reduced−83,430 | |
| Instil Bio IncTIL | COM NEW | 45783C200 | 0.8 | 0.2% | 99,600 | Reduced−83,430 | |
| Tscan Therapeutics IncTCRX | COM | 89854M101 | 0.4 | 0.1% | 454,876 | New+454,876 | |
| Tscan Therapeutics IncTCRX | COM | 89854M101 | 0.4 | 0.1% | 454,876 | New+454,876 |
Sold out: 13 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics IncDMAC | COM NEW | 25253X207 | 0.0 | 0.0% | 0 | Sold out−62,488 | |
| DiaMedica Therapeutics IncDMAC | COM NEW | 25253X207 | 0.0 | 0.0% | 0 | Sold out−62,488 | |
| Kalaris Therapeutics IncKLRS | COM | 482929106 | 0.0 | 0.0% | 0 | Sold out−135,585 | |
| Kalaris Therapeutics IncKLRS | COM | 482929106 | 0.0 | 0.0% | 0 | Sold out−135,585 | |
| Longeveron IncLOOP | COM | 543518104 | 0.0 | 0.0% | 0 | Sold out−347,539 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 0.0 | 0.0% | 0 | Sold out−118,524 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 0.0 | 0.0% | 0 | Sold out−118,524 | |
| PepGen IncPEPG | COM | 713317105 | 0.0 | 0.0% | 0 | Sold out−1,000,000 | |
| PepGen IncPEPG | COM | 713317105 | 0.0 | 0.0% | 0 | Sold out−729,961 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 0.0 | 0.0% | 0 | Sold out−901,457 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 0.0 | 0.0% | 0 | Sold out−901,457 | |
| Tenaya Therapeutics IncTNYA | COM | 87990A106 | 0.0 | 0.0% | 0 | Sold out−2,000,000 | |
| Tenaya Therapeutics IncTNYA | COM | 87990A106 | 0.0 | 0.0% | 0 | Sold out−2,000,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0002106181-26-000007 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.